NCT04580706

Brief Summary

This is a prospective observational clinical trail which will recruit 1000-1500 participants over 65 years with frailty and acute coronary syndrome (ACS) in Beijing Friendship hospital. The investigators will conduct frailty assessment (FRAIL scale, CFS, SPPB), comorbidities, functional status (Barthel index, ADL, IADL), nutritional risk (MNA-SF), and then observe the clinical outcomes of elderly ACS participants with frailty. Then, the investigators will follow-up these participants separately in 1,3,6 and 12months, the anticipate follow-up time is 1 year. According to the follow-up results, investigators will evaluate the impact of frailty and other senile syndromes on the short-term and long-term prognosis of ACS, and develop a scoring system for the prognosis evaluation of elderly ACS participants.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2020

Completed
27 days until next milestone

First Posted

Study publicly available on registry

October 8, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

October 8, 2020

Status Verified

October 1, 2020

Enrollment Period

1.9 years

First QC Date

September 11, 2020

Last Update Submit

October 7, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • Death

    All-cause death and cardiac death events

    During hospitalization, assessed up to 2 months

  • Major Adverse Cardiac and Cerebrovascular events

    Major Adverse Cardiac and Cerebrovascular events including heart failure, cardiac shock, malignant arrhythmia, myocardial infarction, revascularization, and cerebral infarction

    During hospitalization, assessed up to 2 months

  • Death

    All-cause death and cardiac death events

    1 year

  • Major Adverse Cardiac and Cerebrovascular events

    Major Adverse Cardiac and Cerebrovascular events including heart failure, cardiac shock, malignant arrhythmia, myocardial infarction, revascularization, and cerebral infarction

    1 year

Interventions

this is an observational study with none intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This registry will include consecutive patients age ≥65 years admitted for ACS

You may qualify if:

  • Elderly participants over 65
  • Clinical diagnosis of acute coronary syndrome
  • Must be able to follow-up
  • Sign in the informed consent

You may not qualify if:

  • Myocardial infarction caused by other acute disease
  • Mental disorders who cannot cooperate to complete the assessment
  • Severe liver dysfunction, kidney disease (CKD 5), end-stage malignant tumor
  • Totally disabled and bedridden

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Friendship hospital

Beijing, Beijing Municipality, 010, China

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of department geriatrics, Beijing Friendship Hospital

Study Record Dates

First Submitted

September 11, 2020

First Posted

October 8, 2020

Study Start

January 1, 2020

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

October 8, 2020

Record last verified: 2020-10

Locations